Medication info
Glipensupreme Tablets (Fenofibrate)

Glipensupreme Tablets (Fenofibrate)

Prescription medicationTabletOral
Ingredient · strength
Fenofibrate›160mg / 1 tablet
Manufacturer / importer
Samchundang Pharm Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
100 tablets/box [(10 tablets/PTP x 10)]
Approval status
Active

MFDS item code 200702596 · Notified 2007.03.02 · Insurance code 651200040

Summary

Main use
Treatment of primary hyperlipidemia (including hypertriglyceridemia and mixed dyslipidemia)
Who takes it
Adults · Children
Adult dose
○ Adults : Administer 160 mg of fenofibrate orally once daily, immediately after a meal. Fenofibrate must be administered in conjunction with dietary therapy. This medicine may be less well absorbed on an empty stomach, so administer it immediately after a meal (except for the 145 mg formulation). ○ Older adults : Dose reduction is generally not required if renal function is not decreased. ○ Patients with renal impairment : Do not administer this medicine to patients with moderate to severe renal impairment (serum creatinine level of 2.5 mg/dL or higher).
Child dose
○ Children : Clinical data on the use of this medicine in children are not yet available.

Ingredients

Manufacturer
Samchundang Pharm Co., Ltd.

Efficacy & effects

Treatment of primary hyperlipidemia (including hypertriglyceridemia and mixed dyslipidemia)

  • Primary hyperlipidemia
  • hypercholesterolemia
  • hypertriglyceridemia
View approved original text

This medication is used for various lipid abnormalities in the blood, including primary hyperlipidemia, specifically hypercholesterolemia and hypertriglyceridemia. It helps improve type IIa hypercholesterolemia, combined types of hypercholesterolemia and hypertriglyceridemia (type IIb, type III), and hypertriglyceridemia (type IV). Through this treatment, it can regulate blood lipid levels and reduce the risk of cardiovascular diseases. Thus, this medication is effectively used in the treatment of lipid disorders.

How to take

Adult dose

○ Adults : Administer 160 mg of fenofibrate orally once daily, immediately after a meal. Fenofibrate must be administered in conjunction with dietary therapy. This medicine may be less well absorbed on an empty stomach, so administer it immediately after a meal (except for the 145 mg formulation). ○ Older adults : Dose reduction is generally not required if renal function is not decreased. ○ Patients with renal impairment : Do not administer this medicine to patients with moderate to severe renal impairment (serum creatinine level of 2.5 mg/dL or higher).

Child dose

○ Children : Clinical data on the use of this medicine in children are not yet available.

Precautions

This medicine should not be used in patients with poor liver function. It should not be administered to patients with moderate to severe kidney dysfunction due to the risk of rhabdomyolysis, which can cause serious muscle damage. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients allergic to this medicine or its components should also refrain from taking it. Patients with gallbladder diseases or gallstones should use caution, as this medication may worsen gallstones. Patients who have experienced photosensitivity reactions while using fibrates or ketoprofen should not be administered this medicine. Children cannot take this medication. Patients with lactose intolerance or specific genetic metabolic disorders should also avoid this medication. Patients allergic to soybean oil, soybeans, or peanuts should refrain from using this medication. Caution is advised for patients with mild kidney impairment or liver dysfunction; dosing should be adjusted and intervals increased as necessary. Patients with blood coagulation disorders or those taking anticoagulants should be vigilant due to the risk of bleeding. Regular monitoring of liver function tests and blood lipid levels is required during the course of this treatment, and adjustments or cessation should be made if abnormalities are found. Rashes, itching, and photosensitivity reactions may occur on the skin, so it is advisable to avoid sun exposure. If symptoms such as muscle pain, cramps, or weakness occur, immediate consultation with a physician is necessary, and in severe cases, discontinuation of the medication is required. Regular blood tests are necessary as there may be a decrease in blood cell counts or abnormalities in liver and kidney functions. This medication may interact with other drugs, especially statins, anticoagulants, and hypoglycemic agents, so caution is necessary when co-administered. There is no specific antidote for overdose, so the prescribed dosage must be strictly followed. It should be kept out of the reach of children, and it is safe not to transfer it to another container.

Side effects

  • Elevated serum aminotransferases
  • liver enlargement
  • cholestatic hepatitis
  • gallstones
  • rash
  • itching
  • photosensitivity reactions
  • hair loss
  • weakness
  • hyperthermia
Show 42 more
  • dizziness
  • headache
  • peripheral neuropathy
  • thromboembolism
  • elevated creatine kinase
  • myalgia
  • muscle cramps
  • arthralgia
  • rhabdomyolysis
  • urticaria
  • photoallergic dermatitis
  • gastrointestinal disturbances
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • abdominal bloating
  • pancreatitis
  • seizure disorders
  • decreased hemoglobin
  • decreased white blood cells
  • eosinophilia
  • elevated serum creatinine
  • eosinophilic pneumonia
  • ventricular arrhythmia
  • fatigue
  • sexual dysfunction
  • weight gain
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • skin rash
  • anaphylaxis
  • angioedema
  • DRESS syndrome
  • exfoliative dermatitis
  • fever
  • systemic organ involvement
  • thrombocytopenia
  • agranulocytosis
  • myopathy
  • pulmonary embolism
  • deep vein thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

100 tablets/box [(10 tablets/PTP x 10)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.